Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joep Lange

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
GMHC Treatment Issues : the Gay Men'S Health Crisis Newsletter of Experimental AIDS Therapies|March 15, 2003
Interview with Joep LangeJoep Lange
Nature Medicine|November 5, 2003
World Bank meeting concludes drug resistance should not prevent distribution of antiretroviral therapy to poor countriesDaniel Kuritzkes, Joep Lange, Debrework Zewdie
AIDS (London, England)|August 24, 2004
Rapid expansion of access to antiretroviral therapy (ART)Debrework Zewdie, Joep Lange, Daniel Kuritzkes
Antiviral Therapy|May 6, 2010
Earlier testing for HIV--how do we prevent late presentation?Yazdan Yazdanpanah, Joep Lange, Jan Gerstoft, et al.
Current HIV/AIDS Reports|November 12, 2014
Treatment as prevention--where next?Mark Hull, Joep Lange, Julio S G Montaner
The Journal of Clinical Investigation|April 3, 2008
The spread, treatment, and prevention of HIV-1: evolution of a global pandemicMyron S Cohen, Nick Hellmann, Jay A Levy, et al.
AIDS (London, England)|March 21, 2003
Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor Monitor test, version 1.5: a case of unexpected vertical transmissionSibyl Geelen, Joep Lange, Jan Borleffs, et al.
Plos One|April 10, 2008
Late entry to HIV care limits the impact of anti-retroviral therapy in The NetherlandsColette Smit, Timothy B Hallett, Joep Lange, et al.
Lancet (London, England)|October 11, 2015
Challenges of health programmes in slumsSteven van de Vijver, Samuel Oti, Clement Oduor, et al.
Lancet (London, England)|July 6, 2004
Creation of a drug fund for post-clinical trial access to antiretroviralsJintanat Ananworanich, Theshinee Cheunyam, Somsong Teeratakulpisarn, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
GMHC Treatment Issues : the Gay Men'S Health Crisis Newsletter of Experimental AIDS Therapies|March 15, 2003
Interview with Joep LangeJoep Lange
Nature Medicine|November 5, 2003
World Bank meeting concludes drug resistance should not prevent distribution of antiretroviral therapy to poor countriesDaniel Kuritzkes, Joep Lange, Debrework Zewdie
AIDS (London, England)|August 24, 2004
Rapid expansion of access to antiretroviral therapy (ART)Debrework Zewdie, Joep Lange, Daniel Kuritzkes
Antiviral Therapy|May 6, 2010
Earlier testing for HIV--how do we prevent late presentation?Yazdan Yazdanpanah, Joep Lange, Jan Gerstoft, et al.
Current HIV/AIDS Reports|November 12, 2014
Treatment as prevention--where next?Mark Hull, Joep Lange, Julio S G Montaner
The Journal of Clinical Investigation|April 3, 2008
The spread, treatment, and prevention of HIV-1: evolution of a global pandemicMyron S Cohen, Nick Hellmann, Jay A Levy, et al.
AIDS (London, England)|March 21, 2003
Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor Monitor test, version 1.5: a case of unexpected vertical transmissionSibyl Geelen, Joep Lange, Jan Borleffs, et al.
Plos One|April 10, 2008
Late entry to HIV care limits the impact of anti-retroviral therapy in The NetherlandsColette Smit, Timothy B Hallett, Joep Lange, et al.
Lancet (London, England)|October 11, 2015
Challenges of health programmes in slumsSteven van de Vijver, Samuel Oti, Clement Oduor, et al.
Lancet (London, England)|July 6, 2004
Creation of a drug fund for post-clinical trial access to antiretroviralsJintanat Ananworanich, Theshinee Cheunyam, Somsong Teeratakulpisarn, et al.
Pageof 6